![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Advisory Council on the Misuse of Drugs. ‘Hidden Harm: Responding to the needs of children of problem drug users. Home Office, ‘The Advisory Council on the Misuse of Drugs’, London 2003
- Day E, George S. Management of drug misuse in pregnancy. Advances in Psychiatric Treatment 2005; 11: 253–261
- Department of Health. ‘Better for your Baby – HIV testing as part of your antenatal care. DoH, London 2002
- Department of Health. Standard 11 maternity Services. DoH, London 2003
- Doggett C, Burrett S, Osborn D A. Home visits during pregnancy and after birth for women with an alcohol or drug problem. Cochrane Database System Reviews 2005; 19, CD004456
- Jenner E. Immunisation against infectious disease. DoH, London 1996; 95–108
- Morrison C, Siney C. Maternity services for drug misusers in England and Wales: a national survey. Health Trends 1995; 27: 15–17
- NICE. Guidance No. 14. Hepatitis C – pegylated interferons, ribavirin and alfa interferon. January, 2004, Reference: TA75
- Sherwood R A, Keating J, Karradia V, Greenough A, Peters T J. Substance misuse in early pregnancy and relationship to fetal outcome. European Journal of Pediatrics 1999; 158: 488–492
- SIGN: Scottish Intercollegiate Guidance Network. Management of hepatitis C. December, 2006
- Spencer J D, Latt N, Beeby P J, Collins E, Saunders J B, McCaughan G W, et al. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. Journal of Viral Hepatitis 1997; 4: 395–409